Methyl ferulic acid alleviates neuropathic pain by inhibiting Nox4-induced ferroptosis in dorsal root ganglia neurons in rats

doi:10.21203/rs.3.rs-2225182/v1

Download PDF

Research Article

Methyl ferulic acid alleviates neuropathic pain by inhibiting Nox4-induced ferroptosis in dorsal root ganglia neurons in rats

https://doi.org/10.21203/rs.3.rs-2225182/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 22 Feb, 2023

Read the published version in Molecular Neurobiology →

You are reading this latest preprint version

Neuropathic pain is a disease that has become one of the major public health problems and a global burden. Nox4-induced oxidative stress can lead to ferroptosis and neuropathic pain. Methyl ferulic acid (MFA) can inhibit the Nox4-induced oxidative stress. This study aimed to estimate whether methyl ferulic acid alleviates neuropathic pain by inhibiting the expression of Nox4 and its induction of ferroptosis. Adult male Sprague‒Dawley rats were subjected to spared nerve injury (SNI) model to induce neuropathic pain. After the establishment of the model, methyl ferulic acid was given 14 days by gavage. Nox4 overexpression was induced by microinjection of the AAV-Nox4 RNAi vector. All groups measured paw mechanical withdrawal threshold (PMWT), paw thermal withdrawal latency (PTWL), and paw withdrawal cold duration (PWCD). The expression of Nox4, ACSL4, GPX4, and ROS was investigated by Western blot and immunofluorescence staining. The changes in iron content were detected by a tissue iron kit. The morphological changes in mitochondria were observed by transmission electron microscopy. In the SNI group, the paw mechanical withdrawal threshold, the paw withdrawal cold duration decreased, the paw thermal withdrawal latency did not change, the Nox4, ACSL4, ROS, and iron content increased, the GPX4 decreased, and the number of abnormal mitochondria increased. Methyl ferulic acid can increase PMWT and PWCD but does not affect PTWL. Methyl ferulic acid decreased Nox4, ACSL4, and ROS levels, and iron content increased GPX4 expression and decreased the number of abnormal mitochondria. By overexpressing Nox4, the PMWT, PWCD, and ferroptosis of rats were more severe than those of the SNI group, but they could be reversed after treatment with methyl ferulic acid. Methyl ferulic acid can alleviate neuropathic pain, which is related to Nox4-induced ferroptosis.

methyl ferulic acid

neuropathic pain

NADPH oxidase 4

ferroptosis

Neuropathic pain, owing to a lesion or disease, is directly affecting the somatosensory system. Based on the position of the lesion or disease, neuropathic pain can be categoried into two types including peripheral and central neuropathic pain [1]. The epidemiological investigation report shows that the global incidence rate of neuropathic pain is approximately 7% ~ 10%. Pain is an extremely unpleasant experience that can lead to people’s anxiety and depression and can also seriously affect people's quality of life [2–4]. Therefore, finding new effective targets in neuropathic pain is critically important [5].

In recent years, growing researches have demonstrated that neuropathic pain has a strong correlation with ferroptosis [6–9]. Ferroptosis is a novel iron-dependent cell death that is Significantly inconsistent with apoptosis. In essence, it is a regulated kind of cell death resulting from lethal lipid peroxidation. Excessive accumulation of oxidizing substances or reduction of reducing substances can lead to cell ferroptosis. Its main feature is mitochondrial damage and an iron-dependent accumulation in lipid reactive oxygen species (ROS). When increasing ROS exceeds the redox content kept by glutathione (GSH) and phospholipid hydroperoxides using GSH as a substrate, ferroptosis occurs [10].

Intracellular iron overload promotes GSH consumption and lipid peroxidation, and oxidative stress reduces the mRNA and protein expression levels of glutathione peroxidase 4 (GPX4). In addition, it also increases the mRNA and protein expression of acyl-CoA synthetase long-chain family member 4 (ACSL4). In addition, iron overload promotes lipid peroxidation and mitochondrial ROS production and reduces mitochondrial membrane potential (MMP), which is consistent with ferroptosis [11]. GPX4 plays so vital a role in regulating ferroptosis, and GSH is an essential cofactor of GPX4. GPX4 is inactivated after GSH consumption, which leads to an increase in cytosolic ROS, thus leading to ferroptosis [12]. Doll researches manifests that ACSL4 is the key regulator of ferroptosis sensitivity and mainly promots ferroptosis by binding polyunsaturated fatty acids to cellular phospholipids, particularly phosphatidylethanolamine [13]. In a neuropathic pain rat model, the expression level of the landmark protein GPX4 which is correlated with ferroptosis, reduced, the level of ACSL4 increased, and iron content increased correspondingly [14].

NADPH oxidase 4 (Nox4) is a key factor that leads to mitochondrial metabolic damage and ferroptosis by increasing the production of mitochondrial ROS (mtROS) and mitochondrial fragmentation, inhibiting mitochondrial respiration and ATP production. In addition, Nox4 can activate oxidative stress-induced lipid peroxidation in cells and inhibit cellular antioxidant processes, promoting ferroptosis [15, 16]. Miao disclosed that Nox4 was high in a rat neuropathic pain model, and sensitivity of pain thresholds like paw mechanical withdrawal threshold and paw withdrawal cold duration was increased. After Nox4 was inhibited, the oxidative stress products were also correspondingly reduced, indicating that Nox4-induced oxidative stress may be partly responsible for neuropathic pain [17]. However, whether ferroptosis is caused by Nox4 in neuropathic pain has not been systematically studied.

Methyl ferulic acid (MFA), a kind of organic acid, originates in traditional Chinese medicine that has antioxidative stress, anti-inflammatory, and antiapoptotic effects. After using MFA in some diseases, it can be observed that the oxidative stress products Nox4 and ROS are reduced, and the degree of damage is reduced [18–21]. Thus, this study aimed to determine whether Nox4-induced ferroptosis pathway in the DRG exists in neuropathic pain and whether MFA alleviates neuropathic pain caused by SNI by inhibiting the Nox4-induced ferroptosis pathway in the DRG of rats.

2.1. Animals and Grouping

Animal experiments consistented with the requirements of the People’s Republic of China on the Administration of Laboratory Animals. Male 10 ~ 12-week-old SD rats (200–250 g) were bought from Jinan Pengyue Experimental Animal Breeding Co., Ltd. (Laboratory animal license No. SCXK 20190003). Rats were kept in a box with 24 ± 2℃ and humidity of 40–50% and subjected to light/dark cycles for 12 h each. They could freely obtain enough water and food. All protocols complied with the Animal Research Committee by Shihezi University (Protocol A2021-074-01).

Modeling: The rats were selected at random to the sham group and the SNI group. The behavioral tests were carried out on the first day before the operation and 1 d, 3 d, 7 d, 14 d, and 21 d after the operation. The dorsal root ganglion (DRG) tissue was taken for subsequent experiments. Drug Administration: rats were randomised into six groups: sham group, SNI group, SNI + MFA 5 mg/kg group, SNI + MFA 10mg/kg group, SNI + MFA 20 mg/kg group and SNI + DMSO group. MFA (3,4-dimethoxycinnamic acid) was purchased from Sigma Chemical Co. (Sigma #D133809-25G) and was dissolved in dimethyl sulfoxide (DMSO) (Sigma #20–139). MFA of different concentrations was given to rats by gavage from the first day after the operation, once a day for 2 weeks. All groups were taken on the 14th day after the operation, and the behavioral tests were carried out on the 1st day before the operation and 1 d, 3 d, 7 d, and 14 d after the operation (Fig. 1A). In vitro virus injection: The rats were selected at random into six groups: sham group, SNI group, SNI + Nox4 RNAi group, SNI + NC RNAi group, SNI + Nox4 RNAi + MFA 10mg/kg group, and SNI + NC RNAi + MFA 10mg/kg group. The virus was injected into the dorsal root ganglia (DRG) four weeks before the SNI modeling. The samples were taken from each group on the 14th day after the SNI operation, and the behavioral tests were conducted on the 1st day before the operation and 1 d, 3 d, 7 d, and 14 d after the operation (Fig. 1B).

2.2. Preparation of the SNI rat model

According to previous studies, SNI was used to prepare neuropathic pain model [22]. The rats were injected with 2% isoflurane (RWD, R510-22). The rats were disinfected routinely and laid with sterile sheets. The skin was cut along the left lower limb sciatic nerve to take apart the biceps femoris and expose the three branches of sciatic nerve. The common peroneal nerve and tibial nerve were ligated with a 4 − 0 wire and cut with scissors, and both of them are closely connected with removal of the distal nerve ends by approximately 3 mm. The nearby sural nerve was well preserved. After the operation, washing wounds with sterile saline cautiously and closed in layers. In the sham group, the sciatic nerve was exposed and isolated, and then sutured.

2.3. Behavioral Assays

Each behavioral test was conducted by two researchers in a double-blind manner. Each researcher measured three times. After the test, the average value of the two researchers' measurement results was taken as the corresponding pain threshold.

2.3.1. Paw mechanical withdrawal threshold (PMWT)

The PMWT of rats was measured according to the method of "up and down" reported by Chaplan [23]. The rats were put on a metal net shaded with transparent plexiglass. The indoor temperature is suitable and the environment is quiet. After being adapted to the environment for at least 30 min, plenty of standardized von Frey fiber filaments were used to stimulate the center of the plantar of the hind limbs of the rats until they were bent into an S-shape, and the stimulation lasted for 6–8 s. The rats were observed to determine whether there was foot contraction or licking reaction throughout the time of stimulation or when the von Frey fiber filaments were removed. If the rat had a rapid foot contraction or licking reaction, it was recorded as a positive reaction “×”. In contrast, it is a negative reaction "O". Substitute the formula to calculate the 50% foot retraction threshold = (10 ^[X_f^{+ kδ]})/10,000 where X_f is the log value of the strength (2.00 g) of the von Frey fiber applied for the first time, δ is the average value of the difference between the log values of the strength of adjacent von Frey fibers (0.224), and k is the look-up value of the positive and negative reaction types.

2.3.2. Paw thermal withdrawal latency (PTWL)

PTWL was assessed as mentioned by the protocol [24]. An analgesia meter (Ugo basil, Stoelting, IL, USA) was perpared to gauge PTWL. The rats were put above the glass plate of the analgesia meter and permitted to acclimatize for 30 min ahead of testing. The parameters of the analgesia meter were adjusted to 53℃ and the interruption time was 30 s to prevent scalding of the rats. A radiant heat source was focused under the glass floor beneath the hind paws. When the pain prompts the rat to lift the hind foot, the instrument automatically takes the time. This time is the paw thermal pain threshold. During the measurement, the excrement on the glass plate was wiped in time to avoid affecting the results.

2.3.3. Paw withdrawal cold duration (PWCD)

The PWCD was evaluated on the basis of the protocol described previously [25]. The rats were put on a glass plate with a Plexiglas cover and permitted to acclimatize for 30 minutes. We put dry ice into a 3 ml syringe with the tip cut open and compress the ice. The tip of the compressed dry ice particles was extended out of the edge of the syringe to test the hind paws of rats in a completely resting state. The time from dry ice contacting the glass plate to the rats leaving the cooled glass plate was recorded.

2.4. AAV Generation and AAV Microinjections

HBAAV-hSyn-r-Nox4-3xflag-ZsGreen viruses were donations from Hanbio Biotechnology Co. Ltd. (Shanghai, China). AAV virus was microinjected into the left L4-5 DRG adapted from prieviously published method [26]. After rats were anesthetized, fixed, disinfected, and spreadsheets, the intervertebral foramen was carefully separated and exposed in layers. The L_4-5 DRGs can be discovered by removing the laminar bone. Virus injection was performed using a stereotactic device (Beijing Zhongshi Dichuang Technology Development Co., Ltd.). AAV (2 µL) was slowly injected into the DRG within 5 min, and then the glass pipette was placed in situ for at least 5 min. After injection, the wound was sutured and then the rats were put on a constant temperature heating pad for recovery and finally placed in a separate cage.

2.5. RNA extraction and analysis by RT‒PCR.

RNA was extracted from the intact DRG using a TRIzol RNA extraction kit (Invitrogen) and reverse-transcribed to cDNA using a qRT‒PCR kit (Invitrogen) according to the manufacturer’s instructions. For each cDNA target, 2 µl aliquots of each completed reverse transcriptase reaction were amplified in a 20 µl reaction volume using SYBR Green Real-Time PCR Master Mix (Toyobo Co., Ltd., Osaka, Japan) in 45 cycles of 95°C and 60°C for 12 s and 35 s, respectively. The primers prepared for Nox4 were enumerated: Nox4 forward (5′-TGGCCAACGAAGGGGTTAAA-3′), Nox4 reverse (5′-TCCTAGGCCCAACATCTGGT-3′); GAPDH forward (5′-CATGGCCTTCCGTATTCCTA-3′), GAPDH reverse (5′-GCCTGCTTCACCACCTTCTT-3′).

2.6. ROS determination

ROS were measured using a fluorescent probe (BB-470516 Bestbio). Fresh tissues (within 1 hour after surgical resection) were taken, and 10–20 um thick frozen sections were made without fixation. Cleaning solution was added to the frozen section and allowed to stand for 3–5 minutes Then, the cleaning solution was removed, and we added the staining probe working solution. The sections were cultured at 37°C for 20–60 minutes. Staining solution was removed, and coverslips were added after cleaned by PBS. Finally, we observed the sections with the use of a confocal laser scanning microscope (LSM710; Carl Zeiss AG, Oberkochen, Germany).

2.7. Transmission electron microscopy

After the rats were killed quickly, the DRGs of the operation side were taken and cut into ^{1 mm2} sections. Tissue specimens were prepared by prefixation, postfixation, block staining, gradient dehydration, and embedding. Ultrastructural organelles were inspected with the use of a transmission electron microscope (FEI Tecnai G2 F30).

2.8. Iron content assay

The iron content of the rat DRG was detected by the colorimetric method (A039-2-1, Nanjing, China) at 520 nm. The L_4-6 DRG was accurately weighed on the model side of the rats, and 9 times the volume of normal saline was added according to the ratio of weight (g): volume (mL) = 1:9. Samples were mechanically homogenized under ice water bath conditions, rotated at 2500 rpm, and centrifuged for 10 min. The supernatant was collected to determine absorbance OD value. Calculation formula: tissue iron content = (A_measurement - _{Ablank/Astandard} - A_blank) × C_standard ÷ CPR, C_standard is 55.847 g/mol, CPR is the protein concentration of tissue homogenate. The iron content of the DRG is calculated by substituting the measurement results into the calculation formula.

2.9. Immunofluorescence(IF)

The L_4-6 dorsal root ganglia of the operation side were taken and placed in 4% paraformaldehyde overnight, then dehydration in 20% or 30% sucrose in phosphate buffer at 4 ℃ was performed. We cut the tissue into 5-µm thick sections using a cryostat (Leica CM1950, Germany). The sections were blocked with 20% bovine serum albumin (BSA) for 1 h in a 37°C incubator (303-0S; Beijing Ever Bright Medical Treatment Instrument Co., Ltd., Beijing, China), washed with phosphate-buffered saline (PBS), and incubated with primary antibodies overnight at 4°C. The following antibodies were mainly used: rabbit anti-NADPH oxidase 4 (1:500, Abcam #ab133303), rabbit anti-ACSL4(1:200, Boster #A04372-2), and rabbit anti - GPX4 (1:50, Boster #BM5231). After washing with PBS, sections were incubated with secondary antibodies (1:2000, Abcam #ab8135) for 1 h at 37°C. For double IF staining, tissue sections were mixed with Nox4 antibody and anti-neuronal marker antibody anti-NEFH/NF200 antibody (1:200, Boster #BM0100), calcitonin gene-related peptide (1:100, Merck #c7113), and IB4 (1:200, Sigma #L2895). Except for IB4-treated tissue sections, other sections were blocked with a mixture of FITC- and TRITC-conjugated secondary antibodies at a dilution of 1:100 at 37°C for 1 h. IB4 was 1:750 mixed with TRITC-conjugated secondary antibody. After washing with PBS, the nuclei were labeled with DAPI or PI, and finally, the tablet was sealed with an anti-fluorescence attenuation sealant. To quantify the fluorescence intensity, the sections of all groups were stained and imaged with the same protocol.

2.10. Western blot analysis

We split off proteins from the frozen DRG tissue by sodium dodecyl sulfate‒polyacrylamide gel electrophoresis (10–15% gel), and then transferred to 0.45 um polyvinylidene fluoride (PVDF) membranes. We blocked the membranes in 5% milk for 1 h and incubated overnight at 4°C with antibodies: rabbit anti-NADPH oxidase 4 (1:1500, Abcam #ab133303), rabbit anti-ACSL4 (1:1000, Boster #A04372-2), rabbit anti-GPX4 (1:1000, #Boster BM5231). The next day, the membranes were rinsed three times with the use of TBS-T for 10 min each time and incubated with a secondary antibody (GE Healthcare, Chicago, IL, United States) for 2 hours. Finally, chemiluminescent reagents (GE Healthcare, Chicago, IL, United States) were added to examine the blots. The blot intensity was quantitatively analyzed by ImageJ software (Rawak Software Inc., Germany).

2.11. Statistical analysis

Statistical analyses were carried out using GraphPad Prism 9.4.0 (GraphPad Software, La Jolla, CA, United States). Before further statistical analysis, the normal distribution hypothesis of the test data and the homogeneity of variance were examined. we analyzed PMWT, PTWL, and PWCD with the use of repeated-measures analysis of variance, and conducted multiple comparisons between groups each time with the help of Bonferroni’s post hoc tests. Student's t test and one-way analysis of variance (ANOVA) were used to test the significance of data with normal distribution. Nonnormally distributed data were analyzed with the use of a nonparametric Mann‒Whitney U test. The level of significance for all outcome was 0.05.

3.1. The neuropathic pain model was successfully established, Nox4 expression increased, and ferroptosis occurred on DRG neurons of SNI Model Rats

We found no markedly differences in PMWT, PWCD, or PTWL between the rats in each group on the day before surgery (P > 0.05). By contrast with the sham group, the SNI group produced significant mechanical and cold hypersensitivities in rats throughout the 21 days after surgery (P < 0.001). No markedly correlation was found in PTWL between the SNI group and the sham group (P > 0.05) (Fig. 2A, B, C). These results revealed that our neuropathic pain model was definitively built.

IF and WB analyses illustrateed weak, cytoplasmic Nox4 and ACSL4 expression in DRG neurons before surgery. In contrast the expression of GPX4 was strong in the cytoplasm of DRG neurons. In contrast with that in the sham group, Nox4 and ACSL4 accumulated after SNI injury (P < 0.001), however, the expression of GPX4 gradually decreased after SNI injury(P < 0.001) (Fig. 2D-M). In addition, IF demonstrated that the expression of ROS gradually increased with time after SNI injury (P < 0.001) (Fig. 2N, O). These findings indicate that Nox4 expression is increased in neuropathic pain and that ferroptosis-related proteins are activated.

3.2. Nox4 can be expressed in large, medium, and small neurons of the DRG in SD rats

Immunofluorescence double staining experiments manifested to us that Nox4 protein colocalized with CGRP, IB4, and NF-200 (Fig. 3A). The percentages of CGRP, IB4 and NF-200 positive neurons relative to the percentage of Nox4-positive cells were 22.80 ± 5.919%, 38.63 ± 10.86%, and 29.15 ± 9.482%, respectively (Fig. 3B). The results demonstrated that Nox4 was mainly positioned in A- and C-type neurons in the DRG. The neuronal diameter size ranges of CGRP, IB4, and NF-200 were 19.61 ± 2.812, 25.94 ± 4.182, and 44.59 ± 4.272, respectively (Fig. 3C). These results suggest that Nox4 may be related to neuropathic pain.

3.3. MFA inhibited the increase in Nox4 expression and ferroptosis induced by SNI injury and increased the threshold of PMWT and PWCD

First, before building the SNI model, the basic values of the pain threshold of all experimental rats were precisely measured. The difference in PMWT, PTWL, or PWCD among the groups has no marked correlation (P > 0.05). After SNI injury, PMWT and PWCD in the SNI group were decreased in contrast to the sham group (P < 0.001). Then, the PMWT and PWCD of the SNI + MFA 5 mg/kg, SNI + MFA 10 mg/kg, and SNI + MFA 20 mg/kg groups rats were substantially accumulated in contrast with those from the SNI-Vehicle and SNI groups (P < 0.001). No markedly correlation happened in analgesic effect between the SNI + MFA 20 mg/kg and SNI + MFA 10 mg/kg groups (P > 0.05). No clear relationship occured in PTWL among the group. (P > 0.05) (Fig. 4A, B, C).

After MFA injection, L_4 − 6 DRG neurons were collected on day 14 of SNI. Immunofluorescence and WB analysis illustrated that, compared with SNI + MFA 5 mg/kg, SNI + MFA 10 mg/kg and SNI + MFA 20 mg/kg groups, Nox4, ACSL4 and ROS expressions were significantly lower, and GPX4 expression was markedly higher than that in the SNI group (P < 0.001). There was no substantial correlation between the SNI + Vehicle and SNI groups (P > 0.05). Among them, there was no marked correlation in the treatment effect between the SNI + MFA 10 mg/kg group and the SNI + MFA 20 mg/kg group (P > 0.05), but a difference occured in the treatment effect compared with the SNI + MFA 5 mg/kg group (P < 0.05) (Fig. 4D-O).

The results we got suggest that MFA may suppress the expression of Nox4 and alleviate ferroptosis and neuropathic pain.

3.4. MFA can reverse ferroptosis and neuropathic pain caused by Nox4 overexpression

To further verify that MFA can attenuate neuropathic pain by inhibiting Nox4 to alleviate ferroptosis, in vivo overexpression of Nox4 was accomplished by stereotactic injection of AAV-Nox4 RNAi into the DRG. First, the Nox4 transfection range and transfection efficiency were evaluated by immunofluorescence, Western blotting, and qRT‒PCR. We established that AAV-Nox4 RNAi rats exhibited increased Nox4 protein expression in contrast with AAV-NC RNAi rats 28 days after injection (P < 0.001) (Fig. 5).

Next, for a more in-depth analysis of the effect of Nox4 overexpression on neuropathic pain, we initially injected AAV-Nox4 RNAi, established SNI injury models, and administered MFA intervention. In the SNI model, we observed that the thresholds of PMWT and PWCD were significantly increased by preoverexpressing Nox4 (P < 0.001) and were reversed after gavage treatment with MFA (P > 0.05). There was no substantial correlation in PTWL between all groups (P > 0.05) (Fig. 6A, B, C). Through IF and WB analysis, in contrast with the SNI + Nox4 RNAi group, the expression of Nox4 was markedly higher than that in the SNI + NC RNAi group and the SNI group (P < 0.01). At the same time, we also found that in comparison with the SNI + NC RNAi group and the SNI group, ACSL4 and ROS were correspondingly higher, and GPX4 was correspondingly lower (P < 0.05). These results that Nox4 may cause ferroptosis in neuropathic pain. In addition, we observed that compared with the SNI + Nox4 RNAi + MFA 10 mg/kg group, the expression of the ferroptosis-related protein ACSL4 was lower, GPX4 was higher, and ROS was also lower than those in the SNI + Nox4 RNAi group (P < 0.001) (Fig. 6D-O). Therefore, MFA may reverse neuropathic pain when Nox4 expression was inhibited and its induction of ferroptosis in DRG neurons.

3.5. MFA protects against SNI-induced morphological changes in mitochondria in DRG neurons

The ultrastructure of DRG was examined by transmission electron microscopy on the 1st, 3rd, 7th, 14th, and 21st days after SNI injury. The mitochondria in DRG neurons illustrated changes characteristic of ferroptosis, including mitochondrial membrane thickening, mitochondrial shrinkage, and mitochondrial sputum disappearance (Fig. 7A). Additionally, the percentage of mitochondria with morphological abnormalities in the SNI group was zccumulated in comparison with that preoperatively (P < 0.01) (Fig. 7B). To further analyze the changes in mitochondria that were related to Nox4 overexpression, in vivo overexpression of Nox4 was carried out with the use of stereotactic administration of AAV-Nox4 RNAi into the DRG. We found that the percentage of mitochondria with morphological abnormalities in the SNI group was lower than that in the SNI + Nox4 RNAi group (P < 0.05). Finally, we found that compared with that in the SNI group and SNI + Nox4 RNAi group, the percentage of mitochondria with morphological abnormalities in the SNI + Nox4 RNAi + MFA 10 mg/kg group was decreased (P < 0.001) (Fig. 7C-F).

3.6. Iron accumulation induced by SNI was suppressed by MFA

As contrasted with the preoperative values, the iron content in the DRG of rats increased significantly on day 14 after SNI injury (P < 0.01) (Fig. 7G). Thus, iron accumulation happened during SNI in the neuropathic pain model. Treatment with MFA substanly reduced iron concentrations in SNI rats in opposition to the SNI + Vehicle and SNI groups (P < 0.05) (Fig. 7H). After microinjection of the AAV virus into the DRG, the iron content of the SNI + Nox4 RNAi group was higher than that of the SNI group and SNI + NC RNAi group (P < 0.05). However, after MFA treatment, the iron content of the SNI + Nox4 RNAi + MFA 10 mg/kg group was markedly lower than that of the SNI + Nox4 RNAi group (P < 0.001) (Fig. 7I).

At present, neuropathic pain affects more than 1 million people worldwide. Due to its complex mechanism, it cannot be effectively treated at present. Thus, it is critically vatal to explore new technologies or develop effective drugs [27]. Neuropathic pain is caused by the retrograde transmission of peripheral "injury signals" from the injured site to the DRG, causing hyperexcitability of DRG neurons, which form synapses with spinal dorsal horn (SDH) neurons and ultimately project to the thalamus and cerebral cortex [28, 29]. Researches showed that inhibiting oxidative stress in DRG can diminish neuropathic pain [30, 31]. MFA has an obvious effect on antioxidative stress [32]. Therefore, this study aimed to prove that MFA can alleviate neuropathic pain.

In this study, we successfully established a neuropathic pain SNI model. We observed that PMWT and PWCD significantly decreased from 1 day after the operation and continued to the end of the experiment on day 21 day. In related studies, it was reported that the neuropathic pain caused by SNI lasted longer [33]. However, there was no significant change in PTWL, which was in agreement with the results of Xu et al. [34]. After MFA treatment, we observed that PMWT and PWCD were significantly improved compared with the SNI group, confirming that MFA may alleviate neuropathic pain.

We further explored the molecular mechanism by which MFA alleviates pain. Studies have shown that Nox4 overexpression can increase the level of oxidative stress in the spinal cord and DRG and cause neuropathic pain [35]. In this study, Nox4 was expressed in large, medium, and small DRG neurons in the immunofluorescence double labeling experiment. In addition, IS and WB analysis implied that the Nox4 level in the DRG on the affected side of rats was significantly increased 14–21 days after SNI. Hwever, the increase in Nox4 protein was reversed after MFA administration. This change was parallel to the results of behavioral PMWT and PWCD. This result suggests that MFA may alleviate neuropathic pain by inhibiting Nox4 protein in the DRG.

The results prescribe that ferroptosis is one of the important mechanisms involved in neuropathic pain. ACSL4 and GPX4 are ferroptosis marker proteins. During ferroptosis, ACSL4 expression increases, and GPX4 has the opposite effect [14]. On top of that, ROS increase and iron accumulation also play a key role in ferroptosis [36, 37]. Nox4 can increase ROS to cause oxidative stress and ferroptosis in cells [15, 38]. The inhibitory effect of MFA on Nox4 may reduce ferroptosis and alleviate neuropathic pain. In this study, IS and WB analysis showed that ACSL4 expression was significantly higher and GPX4 expression was significantly lower in the SNI injury group than in the sham group. The ROS fluorescence probe also showed that ROS increased. At the same time, the iron concentration was significantly elevated. In addition, transmission electron microscopy of DRG on the affected side showed that the mitochondrial volume was reduced, the membrane density was increased, and the mitochondrial cristae disappeared. These data suggest that ferroptosis occurred on the DRG of the affected side after SNI in rats. These changes were accompanied by Nox4 overexpression and increased sensitivity to PMWT and PWCD. At 14 days after MFA administration, we perceived that the expression of ACSL4 and GPX4 was reversed, and the ROS and iron contents were reduced. In addition, electron microscopy showed that the damaged mitochondria were reduced. Therefore, Nox4 overexpression on DRG neurons may cause ferroptosis and neuropathic pain. MFA may alleviate neuropathic pain by inhibiting Nox4 to alleviate ferroptosis.

To further verify that MFA regulates ferroptosis and alleviates neuropathic pain by regulating Nox4 expression In the DRG, an adeno-associated virus vector and stereotactic microinjection were used to increase Nox4 expression in the DRG. The results demonstrated the Nox4 in the SNI + Nox4 RNAi group was markedly higher than that in the SNI + NC RNAi group. Meanwhile, through IS and WB analysis, we declared that ACSL4 increased, GPX4 decreased, and ROS and iron ions increased. In addition, electron microscopy showed that mitochondrial damage increased. These results indicated that Nox4 overexpression in the DRG causes ferroptosis. In addition, PMWT and PWCD thresholds also decreased. Therefore, ferroptosis caused by increased Nox4 leads to neuropathic pain. Next, we treated the SNI + NOX4 RNAi group with MFA. The results showed that Nox4 expression was decreased, ferroptosis was alleviated, and PMWT and PWCD thresholds were increased. Therefore, we confirmed that MFA can inhibit Nox4-induced ferroptosis in DRG neurons and alleviate neuropathic pain in rats.

There are still some deficiencies in this study. We only focused on the fact that MFA can alleviate neuropathic pain by inhibiting Nox4 expression on DRG neurons, but its specific mechanism was not discussed. Nox4 can be expressed on the mitochondrial membrane and can produce ROS [39]. How does MFA combine with Nox4 to produce inhibition? We will solve this problem in future research. In addition, we only confirmed the existence of cell ferroptosis in the DRG in neuropathic pain, but the underlying mechanism of ferroptosis leading to neuropathic pain has not been discussed, so further research is needed to solve these problems.

To sum up, we demonstrated that Nox4 overexpression in the DRG can cause ferroptosis and can lead to neuropathic pain and that MFA can alleviate neuropathic pain by inhibiting the increase in Nox4 in the DRG. This may provide a new drug choice for neuropathic pain.

Ethics approval

All protocols complied with the Animal Research Committee by Shihezi University (Protocol A2021-074-01).

Consent to participate

Not applicable.

Consent for Publication

Not applicable.

Date Availability

The data of this study are available from the corresponding author upon reasonable request.

Competing interests

None of the co-authors have any conflicts of interest to declare.

Funding

This study was supported by the National Natural Science Foundation of China (No. 82160235) and the Scientific Research Project of Shihezi University (No. ZZZC202068A).

Author contributions

J-W Y, R-X W and Z-G D contributed to the study design and revised the manuscript. T-L L, W-Q Q and L J conducted the experiment and collected and analyzed the data. K-T M, J-Q S, J-T Y and Y-J Z provided assistance in performing the experiments. T-L L and R-X W wrote the manuscript. All authors gave final approval of the manuscript.

Acknowledgments

We thank American Journal Experts (www.aje.com) for its linguistic assistance during the preparation of this manuscript.

Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18):1630–1635. https://doi.org/10.1212/01.wnl.0000282763.29778.59
Bouhassira D (2019) Neuropathic pain: Definition, assessment and epidemiology. Rev Neurol (Paris) 175(1–2):16–25. https://doi.org/10.1016/j.neurol.2018.09.016
Cherif F, Zouari HG, Cherif W, Hadded M, Cheour M, Damak R (2020) Depression Prevalence in Neuropathic Pain and Its Impact on the Quality of Life. Pain Res Manag 2020:7408508. https://doi.org/10.1155/2020/7408508
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primers 3:17002. https://doi.org/10.1038/nrdp.2017.2
Alles SRA, Smith PA (2018) Etiology and Pharmacology of Neuropathic Pain. Pharmacol Rev 70(2):315–347. https://doi.org/10.1124/pr.117.014399
Guo Y, Du J, Xiao C, Xiang P, Deng Y, Hei Z, Li X (2021) Inhibition of ferroptosis-like cell death attenuates neuropathic pain reactions induced by peripheral nerve injury in rats. Eur J Pain 25(6):1227–1240. https://doi.org/10.1002/ejp.1737
Jia S, Chen G, Liang Y, Liang X, Meng C (2021) GCH1-regulated miRNAs are potential targets for microglial activation in neuropathic pain. Biosci Rep 41(9). https://doi.org/10.1042/bsr20210051
Tang Y, Liu C, Zhu T, Chen H, Sun Y, Zhang X, Zhao Q, Wu J, Fei X, Ye S, Chen C (2022) Transcriptome Profiles of IncRNA and mRNA Highlight the Role of Ferroptosis in Chronic Neuropathic Pain With Memory Impairment. Front Cell Dev Biol 10:843297. https://doi.org/10.3389/fcell.2022.843297
Zhang X, Song T, Zhao M, Tao X, Zhang B, Sun C, Wang P, Wang K, Zhao L (2022) Sirtuin 2 Alleviates Chronic Neuropathic Pain by Suppressing Ferroptosis in Rats. Front Pharmacol 13:827016. https://doi.org/10.3389/fphar.2022.827016
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Chen GH, Song CC, Pantopoulos K, Wei XL, Zheng H, Luo Z (2022) Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway. Free Radic Biol Med 180:95–107. https://doi.org/10.1016/j.freeradbiomed.2022.01.012
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1–2):317–331. https://doi.org/10.1016/j.cell.2013.12.010
Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, Prokisch H, Trümbach D, Mao G, Qu F, Bayir H, Füllekrug J, Scheel CH, Wurst W, Schick JA, Kagan VE, Angeli JP, Conrad M (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13(1):91–98. https://doi.org/10.1038/nchembio.2239
Wang H, Huo X, Han C, Ning J, Chen H, Li B, Liu J, Ma W, Li Q, Yu Y, Shi K (2021) Ferroptosis is involved in the development of neuropathic pain and allodynia. Mol Cell Biochem 476(8):3149–3161. https://doi.org/10.1007/s11010-021-04138-w
Park MW, Cha HW, Kim J, Kim JH, Yang H, Yoon S, Boonpraman N, Yi SS, Yoo ID, Moon JS (2021) NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases. Redox Biol 41:101947. https://doi.org/10.1016/j.redox.2021.101947
Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, Chi JT (2019) The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. Cell Rep 28(10):2501–2508e2504. https://doi.org/10.1016/j.celrep.2019.07.107
Miao F, Wang R, Cui G, Li X, Wang T, Li X (2019) Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin. Neurotox Res 36(4):712–723. https://doi.org/10.1007/s12640-019-00039-5
Cheng Q, Li C, Yang CF, Zhong YJ, Wu D, Shi L, Chen L, Li YW, Li L (2019) Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chem Biol Interact 299:131–139. https://doi.org/10.1016/j.cbi.2018.12.006
Cheng Q, Li YW, Yang CF, Zhong YJ, He H, Zhu FC, Li L (2018) Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells. Chem Biol Interact 291:180–189. https://doi.org/10.1016/j.cbi.2018.06.028
Li C, Li L, Yang CF, Zhong YJ, Wu D, Shi L, Chen L, Li YW (2017) Hepatoprotective effects of Methyl ferulic acid on alcohol-induced liver oxidative injury in mice by inhibiting the NOX4/ROS-MAPK pathway. Biochem Biophys Res Commun 493(1):277–285. https://doi.org/10.1016/j.bbrc.2017.09.030
Li L, Zhong Y, Ma Z, Yang C, Wei H, Chen L, Li C, Wu D, Rong MZ, Li Y (2018) Methyl ferulic acid exerts anti-apoptotic effects on L-02 cells via the ROS-mediated signaling pathway. Int J Oncol 53(1):225–236. https://doi.org/10.3892/ijo.2018.4379
Xu ZZ, Chen QY, Deng SY, Zhang M, Tan CY, Yang W, Ma KT, Li L, Si JQ, Zhu LC (2019) 17β-Estradiol Attenuates Neuropathic Pain Caused by Spared Nerve Injury by Upregulating CIC-3 in the Dorsal Root Ganglion of Ovariectomized Rats. Front Neurosci 13:1205. https://doi.org/10.3389/fnins.2019.01205
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55–63. https://doi.org/10.1016/0165-0270(94)90144-9
Xu X, Fu S, Shi X, Liu R (2019) Microglial BDNF, PI3K, and p-ERK in the Spinal Cord Are Suppressed by Pulsed Radiofrequency on Dorsal Root Ganglion to Ease SNI-Induced Neuropathic Pain in Rats. Pain Res Manag 2019:5948686. https://doi.org/10.1155/2019/5948686
Brenner DS, Golden JP, Vogt SK, Gereau, RWt (2015) A simple and inexpensive method for determining cold sensitivity and adaptation in mice. J Vis Exp 97https://doi.org/10.3791/52640
Xiang H, Liu Z, Wang F, Xu H, Roberts C, Fischer G, Stucky C, Caron D, Pan B, Hogan Q, Yu H (2017) Primary sensory neuron-specific interference of TRPV1 signaling by AAV-encoded TRPV1 peptide aptamer attenuates neuropathic pain. Mol Pain 13:1744806917717040. https://doi.org/10.1177/1744806917717040
Shinu P, Morsy MA, Nair AB, Mouslem AKA, Venugopala KN, Goyal M, Bansal M, Jacob S, Deb PK (2022) Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls. J Clin Med 11(11). https://doi.org/10.3390/jcm11113002
Chen Q, Zhang W, Sadana N, Chen X (2021) Estrogen receptors in pain modulation: cellular signaling. Biol Sex Differ 12(1):22. https://doi.org/10.1186/s13293-021-00364-5
Miao B, Yao H, Chen P, Song XJ (2022) Differential Activation of pERK1/2 and c-Fos Following Injury to Different Regions of Primary Sensory Neuron. Life (Basel) 12(5). https://doi.org/10.3390/life12050752
Roch G, Batallé G, Bai X, Pouso-Vázquez E, Rodríguez L, Pol O (2022) The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice. Antioxid (Basel) 11(1). https://doi.org/10.3390/antiox11010122
Zhao X, Liu L, Wang Y, Wang G, Zhao Y, Zhang Y (2019) Electroacupuncture enhances antioxidative signal pathway and attenuates neuropathic pain induced by chemotherapeutic paclitaxel. Physiol Res 68(3):501–510. https://doi.org/10.33549/physiolres.934084
Yang C, Li L, Ma Z, Zhong Y, Pang W, Xiong M, Fang S, Li Y (2018) Hepatoprotective effect of methyl ferulic acid against carbon tetrachloride-induced acute liver injury in rats. Exp Ther Med 15(3):2228–2238. https://doi.org/10.3892/etm.2017.5678
Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87(2):149–158. https://doi.org/10.1016/s0304-3959(00)00276-1
Xu Z, Xie W, Feng Y, Wang Y, Li X, Liu J, Xiong Y, He Y, Chen L, Liu G, Wu Q (2022) Positive interaction between GPER and β-alanine in the dorsal root ganglion uncovers potential mechanisms: mediating continuous neuronal sensitization and neuroinflammation responses in neuropathic pain. J Neuroinflammation 19(1):164. https://doi.org/10.1186/s12974-022-02524-9
Fu CN, Wei H, Gao WS, Song SS, Yue SW, Qu YJ (2021) Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats. Aging 13(14):18606–18619. https://doi.org/10.18632/aging.203305
Li D, Song C, Zhang J, Zhao X (2022) ROS and iron homeostasis dependent ferroptosis play a vital role in 5-Fluorouracil induced cardiotoxicity in vitro and in vivo. Toxicology 468:153113. https://doi.org/10.1016/j.tox.2022.153113
Liu Y, Li L, Yang Z, Wen D, Hu Z (2022) Circular RNA circACAP2 Suppresses Ferroptosis of Cervical Cancer during Malignant Progression by miR-193a-5p/GPX4. J Oncol 2022:5228874. https://doi.org/10.1155/2022/5228874
Poursaitidis I, Wang X, Crighton T, Labuschagne C, Mason D, Cramer SL, Triplett K, Roy R, Pardo OE, Seckl MJ, Rowlinson SW, Stone E, Lamb RF (2017) Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine. Cell Rep 18(11):2547–2556. https://doi.org/10.1016/j.celrep.2017.02.054
Dong G, Huang X, Chen R, Wu L, Jiang S, Chen S (2022) Increased PD-L1 Restricts Liver Injury in Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2022:5954437. https://doi.org/10.1155/2022/5954437

Download PDF

Journal Publication

published 22 Feb, 2023

Read the published version in Molecular Neurobiology →

Reviewers agreed at journal
03 Dec, 2022
Reviewers invited by journal
03 Dec, 2022
Editor invited by journal
19 Nov, 2022
Editor assigned by journal
08 Nov, 2022
First submitted to journal
07 Nov, 2022

You are reading this latest preprint version

Methyl ferulic acid alleviates neuropathic pain by inhibiting Nox4-induced ferroptosis in dorsal root ganglia neurons in rats

Status:

Journal Publication

Version 1

Abstract

Figures

1. Introduction

2. Materials And Methods

2.1. Animals and Grouping

2.2. Preparation of the SNI rat model

2.3. Behavioral Assays

2.3.1. Paw mechanical withdrawal threshold (PMWT)

2.3.2. Paw thermal withdrawal latency (PTWL)

2.3.3. Paw withdrawal cold duration (PWCD)

2.4. AAV Generation and AAV Microinjections

2.5. RNA extraction and analysis by RT‒PCR.

2.6. ROS determination

2.7. Transmission electron microscopy

2.8. Iron content assay

2.9. Immunofluorescence(IF)

2.10. Western blot analysis

3. Results

3.4. MFA can reverse ferroptosis and neuropathic pain caused by Nox4 overexpression

3.5. MFA protects against SNI-induced morphological changes in mitochondria in DRG neurons

3.6. Iron accumulation induced by SNI was suppressed by MFA

4. Discussion

5. Conclusions

Declarations

References

Status:

Journal Publication

Version 1